2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

A Vahanian, F Beyersdorf, F Praz… - European heart …, 2022 - academic.oup.com
Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

Management of patients with aortic valve stenosis

A Kanwar, JJ Thaden, VT Nkomo - Mayo Clinic Proceedings, 2018 - Elsevier
With increased life expectancy and aging of the population, aortic stenosis is now one of the
most common valvular heart diseases. Early recognition and management of aortic stenosis …

2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the …

F Beyersdorf, A Vahanian, M Milojevic… - European journal of …, 2021 - academic.oup.com
731 F. Beyersdorf and A. Vahanian et al./European Journal of Cardio-Thoracic Surgery
guidelines, which is freely available via the ESC and EACTS website and hosted on the EHJ …

The global burden of valvular heart disease: from clinical epidemiology to management

G Santangelo, F Bursi, A Faggiano… - Journal of Clinical …, 2023 - mdpi.com
Valvular heart disease is a leading cause of cardiovascular morbidity and mortality and a
major contributor of symptoms and functional disability. Knowledge of valvular heart disease …

Contemporary trends in the management of aortic stenosis in the USA

M Alkhouli, F Alqahtani, KM Ziada… - European heart …, 2020 - academic.oup.com
Aims To assess the contemporary trends in aortic stenosis (AS) interventions in the USA
before and after the introduction of transcatheter aortic valve implantation (TAVI). Methods …

Treatment of severe symptomatic aortic valve stenosis using non-invasive ultrasound therapy: a cohort study

E Messas, A Ijsselmuiden, D Trifunović-Zamaklar… - The Lancet, 2023 - thelancet.com
Background Calcific aortic stenosis is commonly treated using surgical or transcatheter
aortic valve replacement; however, many patients are not considered suitable candidates for …

Valvular heart disease: from mechanisms to management

F Praz, F Beyersdorf, K Haugaa, B Prendergast - The Lancet, 2024 - thelancet.com
Valvular heart disease is common and its prevalence is rapidly increasing worldwide.
Effective medical therapies are insufficient and treatment was historically limited to the …

Supra‐annular structure assessment for self‐expanding transcatheter heart valve size selection in patients with bicuspid aortic valve

X Liu, Y He, Q Zhu, F Gao, W He, L Yu… - Catheterization and …, 2018 - Wiley Online Library
Objectives To explore assessment of supra‐annular structure for self‐expanding
transcatheter heart valve (THV) size selection in patients with bicuspid aortic stenosis (AS) …

Pre-dilatation versus no pre-dilatation for implantation of a self-expanding valve in all comers undergoing TAVR: the DIRECT trial

K Toutouzas, G Benetos, V Voudris… - JACC: Cardiovascular …, 2019 - jacc.org
Objectives: The aim of this study was to compare the implantation of a self-expanding valve
with or without balloon aortic valvuloplasty (BAV) in an open-label, noninferiority …

Guía ESC/EACTS 2021 sobre el diagnóstico y tratamiento de las valvulopatías: Desarrollada por el Grupo de Trabajo de la Sociedad Europea de Cardiología (ESC) y …

A Vahanian, F Beyersdorf, F Praz, M Milojevic… - Revista española de …, 2022 - Elsevier
Abstract The True Infection Rate (TIR) in the whole population of each country and the
Infection Fatality Rate (IFR) for coronavirus disease 2019 (COVID-19) are unknown although …